Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion
Authors:
Open Access
- 2 March 2013
- journal article
- early detection-and-diagnosis
- Published by Wiley in International Journal of Cancer
- Vol. 133 (6) , 1419-1430
Abstract
Metastasis‐associated in colon cancer‐1 (MACC1) is a newly identified oncogene, and little is known about its role in gastric cancer (GC). Our study was performed to investigate whether MACC1 influences the prognosis of GC patients and to explore the potential mechanisms involved. MACC1 expression was verified to be higher in GC tissues than in adjacent nontumorous tissues by Western blotting. A retrospective analysis of 361 GC patients (Stages I–IV) revealed that higher MACC1 expression was associated with more advanced disease, more frequent postoperative recurrence, more metastases and a higher mortality rate. The disease‐free survival of Stage I–III patients and overall survival of Stage‐IV patients were significantly worse when their tumors showed high MACC1 expression. To investigate the underlying mechanisms, MACC1 overexpression and downregulation were established in two GC cell lines (BGC‐823 and MKN‐28 cells). MACC1 overexpression significantly accelerated tumor growth and facilitated metastasis in athymic mice. MACC1 also promoted the proliferation, migration and invasion of both GC cell lines. Moreover, gastric MACC1 mRNA expression levels were significantly correlated with markers of the epithelial‐to‐mesenchymal transition (EMT) in patients with GC. MACC1 overexpression upregulated mesenchymal–epithelial transition factor and induced changes to markers of EMT, whereas silencing of MACC1 reversed all these changes. These findings provide some novel insights into the role of MACC1, a gene that contributes to a poor prognosis of GC by promoting tumor cell proliferation and invasion as well as the EMT.Keywords
This publication has 28 references indexed in Scilit:
- Silencing of XB130 Is Associated with Both the Prognosis and Chemosensitivity of Gastric CancerPLOS ONE, 2012
- MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon CancerClinical Cancer Research, 2012
- Targeting MET in cancer: rationale and progressNature Reviews Cancer, 2012
- Co‐expression of hepatocyte growth factor and c‐Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c‐Met signaling in gastric cancerInternational Journal of Cancer, 2011
- Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic CorrelationsClinical Cancer Research, 2011
- A Perspective on Cancer Cell MetastasisScience, 2011
- Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancerProceedings of the National Academy of Sciences, 2009
- MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasisNature Medicine, 2008
- Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patientsInternational Journal of Cancer, 2008
- Met, metastasis, motility and moreNature Reviews Molecular Cell Biology, 2003